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Recommendations 
• The target HbA1c for all children with type 1 diabetes, including preschool children, is
recommended to be <7.5% (<58 mmol/mol) (B).
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• This target is chosen with the aim of minimizing hyperglycemia, severe 
hypoglycaemia, hypoglycemic unawareness and reducing the likelihood of 
development of long-term complications (B).  
• Intensive insulin therapy, i.e. as close to physiological insulin replacement as possible 
with preprandial insulin doses and basal insulin, should be used, with frequent glucose 
monitoring and meal-adjusted insulin regimens. (C). 
❖ Insulin pump therapy is the preferred method of insulin administration for young 
children (aged < 7 years) with type 1 diabetes (E). If pump therapy is not available, 
multiple daily injections (MDI), with consideration of use of an injection port, should 
be used from the onset of diabetes (E). 
❖ For preschool children using intensive insulin therapy, preprandial administration of 
bolus insulin given for correction if blood glucose is high and for at least part of the 
meal is preferable to giving the whole dose during or after the meal (C).  
❖ Carbohydrate counting is best introduced at onset of diabetes (E). 
❖ The small insulin doses of preschool children may necessitate diluting insulin for 
precise dosing (E). 
❖ Syringes with ½ unit marking and pens with at least ½ unit dosing increments should 
be used to facilitate more accurate insulin dosing if a pump is not used (or as a back-
up to pump use) (E). 
❖ Continuous glucose monitoring (CGM) can be helpful as an approach to adjusting 
insulin doses (E). Some CGM devices are approved for this use. If CGM is not 
available, 7-10 plasma glucose tests/day are usually needed for satisfactory glucose 
control (E). 
❖ Injection, infusion, and CGM sites should be properly prepared and regularly rotated 
in order to reduce the likelihood of lipohypertrophy, scarring, infection, rashes, skin 
reaction and dry skin (E).  
❖ Injection, infusion and CGM sites should be inspected by diabetes team members at 
every clinic visit to detect and treat any skin problems, such as skin reactions, 
lipohypertrophy or lipohypotrophy (E). 
❖ The use of pumps and CGM are often limited by skin reactions to the adhesive. A skin 
moistener that preserves water can be used to prepare the site a few days prior to 
insertion. Topical cortisone (group I or II) can be used to treat skin reactions and to 
manage itching after removal (E). 
❖ Life style interventions designed to reduce the risk of subsequent cardiovascular 
disease in children with type 1 diabetes are needed, and should be directed towards the 
entire family and not just the individual child with type 1 diabetes (C). 
• Family-centred meal routines with restrictions on continuous eating habits (grazing) 
are important to ensure dietary quality and optimize glycemic control in preschool 
children (C).   
• Diabetes education should be provided to staff at preschools and schools where 
children with type 1 diabetes are enrolled, in order to ensure that equal participation in 
all preschool/school activities occurs and is safely managed (E). 
• Optimal glycemic control, involving the minimising of both hypo- and hyperglycemia 
will give the child the best opportunity to concentrate, participate and learn whilst at 
preschool and school (C). 
• Weight, height (or length if < 18 months) and BMI SDS (or percentiles) should be 
monitored on growth charts in all children with type 1 diabetes (E). 
 
Introduction 
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This chapter focuses on components of care unique to toddlers and preschool-aged children 
with type 1 diabetes. These guidelines are written in particular for children with type 1 
diabetes aged 6 months to 6 years. Children <6 months of age at diagnosis should be 
suspected of having diabetes other than type 1 diabetes, including monogenic diabetes, and 
their management is discussed in the ISPAD guideline on “The diagnosis and management of 
monogenic diabetes in children and adolescents” (1). 
 
Preschool children are dependent on others for all aspects of their care. For the families 
(primarily parents) of preschool children with type 1 diabetes, their diabetes teams, and other 
caregivers, including school and day care staff members and babysitters, treatment is a 
constant challenge. Yet, despite this hurdle, it is important to strive for normoglycemia, as 
current knowledge about the implications of dysglycemia makes reducing the likelihood of 
acute and chronic complications imperative from the time of diabetes onset. Optimizing 
glycemic control for children in this age group often requires treatment using strategies that 
differ from those employed for older children and adolescents with type 1 diabetes. These 
strategies need to take into consideration the cognitive, motor and social immaturity of 
preschool children as well as their small body size and growth pattern. 
 
In addition to their dependence on others for insulin administration and glucose monitoring, 
preschool children are also dependent on others for aspects of their lifestyle related to healthy 
eating and engagement in physical activity. Lifestyle choices and preferences established 
during early childhood provide a window of opportunity for ingraining healthy habits that will 
be perpetuated throughout the child’s life. The early establishment of positive behaviours is 
necessary to ameliorate the high risk of cardiovascular disease that is associated with diabetes. 
Providing adequate education and support of lifestyle changes requires that the multi-
disciplinary diabetes team uses a family-based approach to ensure that the whole family is 
appropriately supported. 
 
Supporting the family is necessary for promoting health in the preschool child with type 1 
diabetes. Early childhood is important for establishing the “salutogenic” (health promoting) 
capacity needed for a long life with type 1 diabetes (2). The core aspect of a person’s 
salutogenic capacity is a good “sense of coherence”, consisting of an everyday perception of 
comprehensibility, manageability and meaningfulness of health promoting actions taken in 
everyday life. The main sources of the child’s salutogenic capabilities are the parents. 
Supporting the parents to endure the burden of intensified insulin treatment, including their 
need for counselling and sleep, is essential to promote and maintain the health and well-being 
of the child. It is also important to support the parents to involve the child in diabetes-related 
tasks such as helping to select finger for monitoring, site for injection/infusion, and to 
encourage age-appropriate positive problem solving strategies when diabetes-related 
problems occur. 
 
Screening and promotion of optimal health related quality of life should be regularly 
undertaken in preschool children with type 1 diabetes as in any child with type 1 diabetes. It is 
important to use validated parent and parent-proxy screening questionnaires to capture factors 
important to the quality of life of children and their parents as both are important and 
impactful on diabetes management.  
 
Children younger than seven years of age with type 1 diabetes constitute a minority of the 
population of all pediatric patients with type 1 diabetes. In small centres this will make the 
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number of very young patients small and the time needed to gain experience in care of this 
patient group will be longer. Close collaboration between centres is necessary in order to 
optimize quality of care for preschool children with type 1 diabetes. 
 
 
Growth and development in the first years of life 
Growth and development in the first years of life are characterized by an intricate interplay 
between genetic, metabolic, hormonal and environmental factors. “Growth” is an increase in 
size of the body and its constituent organs.  “Development” is the differentiation of the form 
and function of the organs, and refers to not only somatic development but also neuro- 
cognitive, and psychosocial development. Rapid changes in growth and development occur in 
the first years of life. 
In the first year of life children grow 25-30 cm, in the second year approximately 12 cm, 
(comparable to the growth spurt in puberty) and in years 3-6 around 6-8 cm per year. Weight 
triples in the first year of life, increases by approximately 2.5 kg in the second year, followed 
by an increase of around 2kg per year in the next 3-4 years. A peak in subcutaneous tissue 
mass is observed around 9 months of age, which subsequently decreases until 6 years of age. 
In order for preschool children to experience normal growth and development, it is essential 
that they maintain near normoglycemia, aiming to increase glucose time in range, and are 
provided with sufficient nutrients (3-6). Restrictive diets or lack of food make it difficult to 
provide essential nutrients for growth and development, and should be avoided.  It is essential 
to monitor weight, height (or length if <18 months) and BMI-SDS (or percentiles) on growth 
charts in all children with type 1 diabetes at every clinic visit.   
This requirement of sufficient nutrition is in part due to the brain’s high metabolic 
expenditure in infancy and childhood (three times higher than in adults).  Body proportion at 
birth is characterized by a large head and prominent abdomen. After birth the brain and the 
cranium continue to grow and reach 4/5 of the adult size by the end of the second year, 
growing much faster than many other body parts including the extremities (7). 
 
The brain and cognitive development in children with early onset type 1 diabetes  
The brain is metabolically highly demanding, accounting for 20% of the total energy 
requirement in adults (8). In the adult, the brain depends on a continuous supply of glucose as 
fuel. In the neonate, glucose is essential for different intracerebral pathways (9). Brain 
development requires different nutrients to support the five key processes: 1) neuron 
proliferation, 2) axon and dendritic growth, 3) synapse formation, pruning and function, 4) 
myelination, 5) neuron apoptosis. Regional and temporal variation in glucose utilization 
suggests that glucose is essential not only for energy production in the brain, but potentially 
for cellular proliferation and synaptogenesis as well (10). In the neonatal and infant brain, 
alternative energy sources may be identified such as ketone bodies, which are transported 
over the blood brain barrier in times of glucose shortage. The ketone bodies are a substrate for 
lipid synthesis, although not essential (11). 
In addition to somatic growth, preschool children experience rapid cognitive development. 
Children start by investigating objects in their immediate environment, eventually expanding 
to exploring anything within reach. Mobility and thus physical activity increases with age.  
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Multiple risk factors have been associated with potential suboptimal cognitive and fine motor 
development in children and adolescents with type 1 diabetes. These factors include early 
onset of disease (typically defined as < 5 years of age) (12), disease duration, history of 
moderate to severe ketoacidosis (including those at diagnosis) (13, 14), severe hypoglycemia 
(including seizures or unconsciousness) (15), cumulative exposure to hyperglycemia, and 
possibly, the sex of child (16). A meta-analysis showed that the risk of cognitive disruption is 
largest for children with early-onset diabetes and that the effect is detectable after a mean 
diabetes duration of six years (17). The mean effect size is moderate but might not be large 
enough to affect school performance.  Clinicians should be concerned about DKA, severe 
hypo- and hyperglycemia, all being detrimental for the health of the preschool child. 
 
When reviewing these findings, it is important to distinguish between statistically significant 
group differences versus clinically significant findings. Statistically significant group 
differences may or may not translate into a functional impact on the daily life of a child, 
which has not been fully explored in children with type 1 diabetes. However, we know that 
early brain and cognitive development are important for later success in school and beyond.  
 
Glucose uptake by the brain is insulin-independent and mainly driven by the concentration of 
glucose. This directly exposes the neuronal cells of the brain to oxidative stress and 
glucotoxicity in hyperglycemia, and to lack of fuel in hypoglycemia.  
 
The maturation of grey matter in the brain is intense throughout the toddler and preschool 
years. Grey matter development slowly curtails over time beginning around puberty. In 
contrast, white matter maturation (that is necessary for processing speed and coordinated, 
fluid movements) continues until early adulthood (18, 19).  
 
During toddler and preschool years, the brain is highly sensitive to metabolic disturbances, 
and potential abnormalities have repeatedly been identified in MRI studies of young brains 
exposed to glycemic extremes, as in type 1 diabetes (20-23). The mechanisms by which early 
brain development is affected by type 1 diabetes are not clearly understood.  Long-term 
exposure to hyperglycemia as well as hypoglycemia (especially with seizures) and oxidative 
stress caused by glycemic variability have been suggested as contributing factors. The main 
effects seem to occur in the early phase of the disease. It has been suggested that metabolic 
conditions such as hyperglycemia and ketoacidosis at diagnosis can be predisposing events 
that makes the brain more vulnerable to subsequent metabolic insults (13, 16).  
 
Some, but not all, studies investigating cognition in childhood onset type 1 diabetes, report 
decrements in the domains of IQ (Verbal IQ in particular), executive functions (attention, 
working memory, response inhibition), delayed memory (episodic recall), and processing 
speed (paper-pencil); however, these differences are generally not reported until the children 
are studied later in childhood (24, 25). One possibility is that chronic exposure to different 
aspects of dysglycemia is additive, and that brain and cognitive changes only become 
apparent over time. 
 
Studies that specifically target the youngest children with type 1 diabetes have found only 
modest differences in cognitive function compared to peers. Among a large group (n=144) of 
children aged 4 to 7 yrs, small differences in the following areas were reported: IQ, especially 
verbal, executive functions and internalizing mood disorders (26). The cognitive differences 
remained when controlled for parental IQ and level of internalizing mood disorders. 
Longitudinal follow up of these children is ongoing and may reveal how these differences 
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change with time, further exposure to diabetes (including hypo- and hyperglycemia), and 
brain development (27).   
 
A young child who has executive functioning difficulties, language/literacy deficits, slowed 
processing speed, or fine motor coordination difficulties will likely require professional 
attention at some point in their youth. Typically, these children are referred to a 
neuropsychologist or other learning specialist during the early elementary years. These 
children can require specialized tutoring, small group instruction, support in the classroom or 
other assistance.  For all children with cognitive development issues, early identification and 
remediation are crucial to avoid poor outcomes.  Optimal glycemic control will give young 
children with type 1 diabetes the best opportunity to concentrate, participate and learn whilst 
at preschool and school. By achieving good glycemic control, including mitigating prolonged 
exposure to hyperglycemia, and by providing early identification and intervention for 
academic, cognitive or motor issues, health care professionals are best able to help children 
avoid any negative impact of type 1 diabetes on everyday function. 
For further reading, the ISPAD guideline on psychological care of children and adolescents 
with type 1 diabetes comprehensively addresses this subject (28). See also the ISPAD 
Guideline on hypoglycaemia (29). 
Glycemic targets and control in preschool children with type 1 diabetes  
Optimizing glycemic control for preschool children with type 1 diabetes is crucial for their 
future, both with respect to acute and long-time diabetes complications as well as their neuro-
cognition, brain structure and health-related quality of life (HRQoL). 
ISPAD published glycemic targets for HbA1c (<7.5%; <58mmol/mol) and for SMBGs (from 
optimal to high risk) in the latest guidelines 2014 (30). See Table 1. The targets are applicable 
to all pediatric age groups, including preschool children, and the aim should be to achieve 
optimal glycemic control. The American Diabetes Association (31) in 2014 redefined blood 
glucose targets for all pediatric age groups to be at the same level as ISPAD (32). In UK, 
glycemic targets for all pediatric age groups are recommended in the NICE guidelines, 
recently updated to an even lower HbA1c level of ≤6.5% (≤48 mmol/mol) (33). (The numbers 
are based on the published guidelines).  
 
  
 ISPAD (30)  ADA (31) NICE (33) 
Preprandial glucose 
target 
4.0-8.0 mmol/l 
(70-145 mg/dL) 
 
5.0 – 7.2 mmol/l 
(90-130 mg/dL) 
4.0-7.0 mmol/l 
(72-126 mg/dL) 
Postprandial glucose 
target (two hours 
post meal) 
5.0-10.0 mmol/l 
(90-180 mg/dL) 
 
 5.0-9.0 mmol/l 
(90-162 mg/dL) 
Bedtime 
 
Overnight 
6.7-10 mmol/l 
(120-180 mg/dL) 
4.5-9.0 mmol/l  
(80-162 mg/dL) 
 
5.0-8.3 mmol/l 
(90-150 mg/dL) 
 
HbA1c target <58 mmol/mol 
(<7.5%) 
<58 mmol/mol 
(<7.5%), a lower 
target of <53  
≤48 mmol/mol 
(≤6.5%) 
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mmol/mol (<7%) 
can be set if it can be 
achieved without 
hypoglycemia 
 
 
It is important that the diabetes team and family share the same target HbA1c and glucose 
ranges. Otherwise there is a high risk of discrepancy that can go both ways. Sometimes 
parents strive for lower glucose levels than the diabetes team, who at times may articulate that 
the family is too strict and take too many glucose tests, especially at night. At other times, the 
parents have their own set of higher glucose targets that they feel fit better with their daily 
life, finding the targets set by the health care team unachievable.  
When evaluating glycemic targets together with the family, it might be useful to express them 
as time spent within target and time below or above target. It is important that both the 
diabetes team and the families consequently use a language that tells the child that a glucose 
value can be high, low or normal, and that the glucose level is never “bad”. The knowledge of 
a glucose value often calls for action, but never for blaming or punishing the child. 
❖ Parents express that diabetes management style can make a difference. A positive, 
nonjudgmental, attitude will likely have a positive influence on the way a young child 
views and manages his/her type 1 diabetes as he/she gets older. Parents should be 
encouraged to adopt a ‘matter-of-fact’ approach to the routines (injections/ pump site 
changes, finger pricks and meal times), treating numbers as just numbers/data points, 
and not apologizing for aspects of care such as finger pricks, site changes, injections  
that cannot be avoided. 
Maximizing the amount of time glucose values are in range needs to be the target for multi-
disciplinary diabetes teams, as well as the family/caregivers. Diabetes education (34, 35) and 
a clearly set glycemic target (36) are very important (37, 38). Age specific challenges need to 
be considered and age-appropriate actions taken to achieve these.  
As discussed above, there are detrimental effects of hyperglycemia; yet it is an existing 
practice to allow glucose levels to reach the hyperglycemic range in the youngest age group in 
order to avoid hypoglycemia at all costs. This is unsafe and treatment should instead aim to 
minimize both hyperglycemia and hypoglycemia in the effort to achieve (near) 
normoglycemia. If the diabetes team is inexperienced in treating preschool children with type 
1 diabetes, support and advice should be sought from more experienced colleagues. 
 
It might not just be the HbA1c level that is important. Glycemic variability may play a role in 
the development of diabetic complications (39, 40), but the long term impact of glycemic 
variability remains controversial (41, 42).  In adults using CGM, glycemic variability was 
significantly lower in those without complications compared to those with complications (SD 
3.4 mmol/l versus 4.1 mmol/l) despite comparable HbA1c values (43). 
Age-specific, family-centered diabetes education plays a key role in achieving metabolic 
targets, together with flexible insulin regimens, glucose monitoring and carbohydrate 
counting (30, 34, 44).  
Hyperglycemia is a major risk factor for (recurrent) ketoacidosis (45) and microvascular 
complications later in life (46, 47). 
8 
 
Long-term tracking of glycemic control from childhood until adulthood has been reported 
(48-52). There is a correlation between the HbA1c achieved within the first few months after 
diabetes diagnosis, the glycemic control later in life and the risk for cardiovascular 
complications. A lower HbA1c achieved at an early phase of life with diabetes is associated 
with a lower HbA1c later on (48-52). 
 
Long-term studies, e.g. the DCCT-EDIC, describe a prolonged effect of prior glycemic levels 
on diabetic complications, called glycemic memory. This effect is independent of more recent 
glycemic control. The DCCT showed a significant difference of around 2% in HbA1c 
between the intensive and conventional groups, but 1 year after the closeout of the study, 
HbA1c levels were approximately the same (around 8%) (46, 47). Nevertheless, the intensive 
group showed fewer microvascular complications, with a risk reduction in retinopathy even 
18 years after the end of the study (53). The DCCT-EDIC results have led to the 
recommendation of early tight glycemic control to reduce the risk for diabetic microvascular 
and macrovascular complications (47, 54, 55). The ISPAD guideline on microvascular and 
macrovascular complications provides a more detailed discussion (56).  
Early onset of diabetes at a very young age will lead to a longer duration, which in itself is 
associated with a higher lifelong risk of complications, compared to persons with later onset 
type 1 diabetes (57). So far, conflicting data exist to whether the prepubertal years contribute 
to the same degree as the pubertal years for the development of microvascular complications 
(58). Sub-optimal metabolic control in children with early prepubertal diabetes onset may 
further contribute to the risk of complications (59-61). Persons with poor glycemic control 
during childhood have a high risk of long-term complications, even if substantial 
improvement is achieved as young adults (62), and NICE emphasizes the need to reduce the 
risk of long-term complications of type 1 diabetes in a population that will have a long 
duration of diabetes because the condition starts before adulthood.  
Insulin therapy in preschool children. 
Insulin treatment guidelines for preschool children are essentially similar to older children and 
adolescents, but age-dependent aspects have to be taken into consideration. See the ISPAD 
guidelines for further reading on insulin and insulin analogs in pediatric use (63). Worldwide, 
most preschool children with diabetes use insulin injections to manage their diabetes. 
Although for many of these children insulin pump use should be considered, injection therapy 
is used in many centres in the following instances: early in the course of the disease in their 
remission period; children who were using an insulin pump but have experienced pump 
failures; and if living in limited resource settings where insulin pumps are unavailable. 
 
Approval of insulin analogs in different age-groups is regulated by authorities. Two examples 
are the European Medicines Agency (EMA) (www.ema.europe.eu) approvals and the U.S. 
Food and drug administration (FDA) (www.fda.gov) as of January 2016 (Table 2). 
 
 Approved by EMA from age Approved by FDA for 
(studied from age) 
Insulin lispro “adults and children” “adults and children” 
(3 years)  
 
Insulin aspart ≥ 2 years “adults and children”  
(2 years)  
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Insulin glulisine ≥ 6 years “adults and children” 
(4 years)  
 
Insulin detemir ≥ 1 year “adults and children”  
(2 years)  
 
Insulin glargine ≥ 2 years “adults and pediatric 
patients” (6 years)  
 
Insulin degludec ≥ 1 year ≥ 1 year 
 
 
When using injections for insulin delivery, pain can be reduced by usage of subcutaneous 
catheters changed every third day (Insuflon® or I-port®) (64). 
Insulin dosing 
 
Preschool children with optimal glycemic control usually need somewhat less insulin than 
older children. The total insulin dose has been reported to be 0.4-0.8 U/kg/day (median 0.6 
U/kg/day) in preschool children with well controlled type 1 diabetes after the remission phase 
(65). Insulin pumps offer both greater flexibility in insulin dosing and a better means to 
deliver very small, precise doses of insulin than when using injections (66), and are thus 
considered the preferred method for insulin delivery in infants, toddlers and preschoolers with 
diabetes, although earlier randomized studies have failed to show an effect on glycemic 
control (63). If pump therapy not is available due to lack of economic resources, multiple 
daily injections (MDI), with consideration of use of an injection port, can be used. If the 
diabetes team is not experienced enough in pump treatment of preschool children, advice 
should be sought from a more experienced center to optimize quality of care. 
 
Basal insulin 
When using injections for insulin treatment, the special diurnal pattern of insulin requirements 
in preschool children should be taken into consideration in designing an individualized basal 
dosing scheme. The low requirement of insulin and tendency toward low glucose levels are 
often most obvious during the night and especially between 3-6 am. Preschool children often 
need much more insulin late in the evening between 9 pm-12 midnight (67-69). This creates 
typical patterns when programming the basal rates of an insulin pump used by a preschool 
child. With MDI (multiple daily injections), a basal insulin analog can reduce hypoglycemia, 
including night-time hypoglycemia, compared to NPH insulin (70-72). 
 
The combination of the low body weight, and thus low total insulin dose, demands special 
consideration when using commercially available insulin pumps. A pump with a very high 
precision in delivering very small basal rates should be chosen for a preschool child. 
Sometimes further reduction in the dose is needed, necessitating dilution of the current U 100 
insulin (65, 73, 74), or an intermittent basal rate of 0 U/h for limited periods i.e. every second 
hour during the night. Use of these approaches may help to meet the needs of the young child 
and the planning of the child’s insulin treatment has to be carefully discussed (with 
advantages and disadvantages) with the parents so they are well aware of the benefits and 
risks of the chosen strategy. The given insulin should always be prescribed and documented in 
normal units to avoid hazardous misunderstandings regarding insulin dosing, especially if the 
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child is admitted to hospital. A pump containing diluted insulin should be labelled with 
information regarding the currently contained concentration of insulin.  (See table 3). 
 
 
 
 
 
 Advantages Disadvantages 
Diluted insulin (ie 10 U/ml 
or 50U/ml) 
• Fine tuning of basal rates 
is possible. 
• All technical features of 
pump can be used, such 
as temporary basal rate 
changes and bolus 
calculations. 
• Possible to set extremely 
low basal rates and make 
changes in small 
increments. 
• Risk of mistakes due to 
the delivered insulin 
dose not being the same 
as that displayed on the 
screen. 
• Pain can occur when 
large volumes are given 
as bolus doses. 
• Impractical to prescribe 
doses with diluted 
insulin 
• More expensive insulin. 
“Empty” hours without 
basal rate. 
• The pump gives exactly 
the doses displayed on 
the screen, decreased risk 
of mistakes in dosing for 
instance when insulin is 
given temporarily with 
pen. 
• Use of more stable 
commercially available 
insulins is possible.  
• Increased risk of 
occlusion in tubing due 
to low flow rate. 
• Increased risk of ketosis 
due to planned hours 
without insulin. 
• Some of the pumps’ 
technical features (as 
temporary basal dose 
changes) cannot be used. 
Table 3. Different strategies for delivering minute basal rates. No pumps that are available 
today can adjust the insulin concentration. Thus, if using diluted insulin, recommended doses 
from the bolus calculator must be recalculated to the diluted concentration.  
 
A glucose and meal-adjusted basal-bolus insulin regimen (delivered by injections or pump) 
requires that the basal rate can be fine-tuned by the parents in accordance with the child’s 
current insulin sensitivity. Insulin sensitivity can be increased after very active days, such as a 
day at the beach or out in the snow (decreased insulin resistance). The overnight basal might 
then be reduced with 10-30% when using a pump or a similar decrease in bedtime long-acting 
insulin. Insulin sensitivity can be markedly reduced (increased insulin resistance) for example 
during fever when the basal rate might need to be increased by 20-100% according to glucose 
levels when using a pump, or a similar increase in dose of long-acting insulin. Under these 
circumstances, glucose levels have to be extremely carefully monitored and parents need 
constant access to support from the diabetes team.   
 
 
 
Bolus dosing 
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Although still often used, twice daily insulin dosing in this age group does not give the 
flexibility needed in adapting doses to varying situations in daily life. It is difficult to fine-
tune, and difficult for the family to understand and adjust on their own, which is a necessity 
for a successful insulin treatment. A glucose and meal-adjusted basal-bolus insulin regimen 
(delivered by injections or pump) can be adapted to the preschool child’s daily activities, and 
is the preferred type of insulin treatment. 
Preschool children often need proportionally larger bolus doses than older children, often 
constituting 60-80 % of the total daily insulin dose (TDD). The often used rule of 500 
(500/TDD = how many grams of carbohydrate is covered by one U of insulin) for bolus 
calculations, as detailed in the ISPAD guideline on insulin therapy (63) rarely fits the 
youngest children as it often underestimates the insulin dose (70, 75, 76). Different strategies 
can be used; either use 330 or 250 rule (gives 50-100% more insulin) instead of 500, or, 
which is preferable, to observe and calculate the correct proportion between insulin and 
carbohydrates from real life meals. To calculate the insulin to carbohydrate ratio from a given 
meal, divide the carbohydrate content in the meal (in grams) by the insulin dose in units that 
gives an appropriate glucose profile after the meal. The need for insulin at breakfast is often 
very high, and one might consider using 150/TDD in the calculation, or calculate from real 
life meals as above.  
The timing of the prandial bolus is important. As outlined in the review by Bell et al (77), 
several studies show that preprandial bolus insulin is preferable to insulin administered during 
or after the meal and should thus be routinely advised for all toddlers and pre-schoolers, even 
the most unpredictable eaters. However, the dose can be split into one pre-prandial and one 
during the meal when eating is erratic or new foods are offered. 
The dose given during the meal can be based on what the parent estimates the child will eat of 
the remaining meal, taking into consideration the food that has just been eaten and the child’s 
remaining appetite. Small inaccuracies in calculation of up to 5-7g carbohydrate will usually 
not be problematic (78). Larger inaccuracies may result in possible hypo- or hyperglycemia 2-
3 hours after eating, but not immediately (79). These can be anticipated and treated with 
additional carbohydrate or a small correction dose of insulin. With a pump, a combination 
bolus (also called combo or dual wave bolus) can be helpful, i.e. part of the bolus is given 
before the meal and the remainder over 20-40 minutes. If the child stops eating before the 
meal is finished, the remainder of the bolus can be suspended. 
When giving these relatively large bolus doses, one must remember that they interact with the 
need for basal insulin in the following hours. Thus, the total basal rate can be relatively low, 
around 20-40% of TDD. In preschool children, it is often estimated that the effect of a 
subcutaneous given bolus of rapid acting insulin analogues (e.g. as lispro, aspart, or glulisine) 
lasts for only 2-3 hours (active insulin time in pumps) (75). 
At breakfast there is often some degree of insulin resistance, and it is common to experience a 
marked glucose peak after breakfast in spite of an adequate insulin dose taken before the 
meal. The nutritional content of the breakfast has to be discussed and planned by the dietitian, 
together with the parents.  Increasing the insulin dose (lower insulin-to-carbohydrate ratio) too 
much can risk hypoglycemia before lunch. In this situation, it may be helpful to give the 
prandial insulin 10-20 minutes before breakfast. The need for a large bolus dose of insulin to 
cover breakfast might necessitate a very low or suspended basal rate during the following 3 
hours. For some children, a small amount of fruit (5-10g of carbohydrates) may be given 2 
hours after breakfast (without insulin) to avoid hypoglycemia, but it is preferable not to 
12 
 
establish a practice that necessitates skipping a bolus as this may continue as the child gets 
older.  
 
When using multiple daily injections (MDI) with frequent glucose testing and meal-adjusted 
insulin dosing, one possible strategy is to give a rapid-acting insulin analog for all meals, with 
the exception of the last meal of the day when short-acting regular insulin can be used to meet 
the increase in glucose before midnight. Part of the dose can be given as rapid-acting analog 
insulin to avoid needing to give the dose 30 min. before the meal; the insulins can be mixed in 
a syringe or given as separate injections (if injection aid is used). 
Nutritional needs of the preschool child with type 1 diabetes 
Breastfeeding should be encouraged for all infants, including infants with diabetes (WHO 
recommendation, www.who.int). Complementary foods, preferably iron-rich, should be 
commenced from 4 to around 6 months of age (80). If breastfeeding is not possible, an iron-
fortified infant formula should be given as the main milk drink until 12 months of age.  
A routine regarding breast- or formula-feeding is important for infants with diabetes as this 
enables appropriate interpretation of glucose levels and basal and bolus insulin adjustments. 
This may involve 3-4 hourly feeds (of approximately 150-240ml) during the day with 
complementary solids. Continuous or hourly breastfeeding is discouraged as this makes 
insulin dosing difficult. Breast milk has approximately 7.4 g carbohydrate (CHO) per 100ml; 
so for infants 6 months and older it is possible to bolus before the feed for at least 5-7g CHO 
and 15g CHO in older babies (>9 months).  
Optimal nutrition is required to provide sufficient energy and nutrients to meet the rapidly 
changing needs of children at this stage of life. Dietary recommendations are based on healthy 
eating principles suitable for all preschool children, with the aim of establishing family based 
meal-time routines that promote glycemic control and reduce cardiovascular risk factors. 
Carbohydrate counting is important to permit the matching of insulin dose to carbohydrate 
intake on intensive insulin regimens (44), and should be taught to the family at the onset of 
diabetes. Nutritional advice must be individualised and adapted to cultural and family 
traditions. A pediatric diabetes dietitian should provide education, monitoring and support at 
regular intervals throughout the preschool years, as parents of preschool children with 
diabetes report meal-times as one of the most difficult components of their child’s care (81). 
Preschoolers require more frequent review than older children (44), with a suggestion for 
reassessment twice annually until age 6 years. 
 
There is international agreement that carbohydrate should not be restricted in children with 
type 1 diabetes as it may result in deleterious effects on growth. Care should be taken when 
giving dietary education that methods of quantifying carbohydrate do not increase total fat 
and/or saturated fat intake (44). Although caregivers may prefer high-fat snacks to avoid 
affecting glucose levels, this should be discouraged as they will provide unnecessary calories, 
an unhealthy fat intake and negatively impact dietary quality.  
 
Preschool children with type 1 diabetes should consume a diet that emphasizes fruit, 
vegetables, whole grain bread and cereals, dairy foods and appropriate types and amounts of 
fats. Low fat diets are not suitable for children under two years of age. Lower glycemic index 
(GI) choices, such as wholegrain bread and cereals can be introduced as substitutes for higher 
GI food choices from two years of age. Iron deficiency can be a concern in this age group; 
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adequate consumption of lean meat or alternatives is important and should not be over-looked 
because of the increased focus on carbohydrate. 
   
A guide to the macronutrient distribution of the total daily energy intake in preschool children 
is as below. However, this should be based on an individualized assessment.  
 
• Carbohydrates: 45-55 Energy (E) % (44, 82).  Average intakes 150g/day in children 
aged 1½- 3 years. 200g/day in children 4-10 years (83). 
 
• Protein: 15-20 E % (decreasing with age from approximately 1.5g/kg body weight/day 
in six month old infants to 1g/kg body weight/day in preschoolers) (84) 
 
• Fat: 30–35 E % (less than10 E% saturated fat, less than 10 E% polyunsaturated fat, 
and more than 10 E% mono-unsaturated fat). Infants less than 12 months may 
consume up to 40% energy from fat.  
 
It is important to encourage all children, including children with type 1 diabetes, to eat plenty 
of fruit and vegetables. Examples of recommendations from Australia (85), USA (86) and the 
Nordic Countries (87) are expressed in different ways but consistent in content, and  state 
180g vegetables (2 ½ servings) and 150g fruit (1 serving) daily from 2 years of age (85); or 1 
½ serving of fruit and vegetables daily between 1 and 3 years (86). 400g fruit/vegetables are 
recommended each day from 4 years of age (87).  
Research has shown the dietary quality of preschool children with diabetes is poorer than their 
healthy peers (88).Studies have shown that preschool children with type 1 diabetes consume 
less fruit and vegetables and have higher saturated fat intakes than peers (89) than 
recommendations would advise (90, 91). Poor food intake may increase the risk of 
cardiovascular disease. Eating habits in young children can influence food choices later in life 
(92), so early intervention with increased attention to an increase in fruit and vegetable intake 
and decrease in saturated fat is needed. Just like healthy children, children with diabetes may 
require up to 10 exposures to a new food before it is accepted (93).  
 
Several studies show that children with type 1 diabetes are more overweight compared with 
children in the general population (91, 94), with the youngest children (<6 years) being the 
most overweight (95, 96). It is important to plot the growth chart including assessments of 
weight for length or height regularly to identify excessive weight gain, in order to commence 
interventions that involve the whole family. Encouraging participation in family meals has 
been recommended to promote dietary quality (97) and social interaction. 
Age-appropriate finger foods should be encouraged for self-feeding, and the reintroduction of 
a bottle as an easy method of carbohydrate intake discouraged. Bottles can lead to 
overconsumption of fluids, increasing carbohydrate intake and placing other nutrients at risk.  
 
Establishing positive food behaviours and meal-time routines  
Establishing positive food behaviours and meal-time routines are important for preschool 
children with type 1 diabetes, as these behaviours impact glycemic control (81, 98) and 
encourage life-long nutrition practices (92). Normal early childhood development, including 
seeking independence, transient food preferences, variable appetite, food refusal and 
behavioural resistance often make meal times challenging for parents and carers. Parents of 
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children with type 1 diabetes report more disruptive meal behaviours, including longer meal 
duration and more frequent food refusal compared to controls (99, 100); even for children 
using insulin pump therapy (101). Research has demonstrated positive correlations between 
suboptimal dietary adherence and higher glucose levels (81, 89, 101, 102). Caregivers’ fear of 
hypoglycemia associated with food refusal or unpredictable dietary patterns can result in force 
feeding, grazing continually over the day and postprandial insulin administration, causing 
prolonged periods of hyperglycemia.   
Family-centred meals are important to model eating practices and to encourage new foods. 
For small children, meal times should be limited to approximately 20 minutes per meal (103). 
Conventional insulin regimens require adherence to a structured plan of carbohydrate intake, 
and parents frequently report problems with this approach (81). Intensive insulin management 
offers greater flexibility in meal timing and carbohydrate quantities.  
 
 
To assist the reliable intake of carbohydrate at meal-times and to minimise food refusal, the 
following strategies should be advised:   
• structured meal-times 
• avoidance of continuous eating habits 
• small snacks including limits on low carbohydrate foods as these fill the child up 
• limits on the time spent at the table 
• avoidance of force feeding 
• reassurance by all team members regarding the usual non-severity of hypoglycemic 
episodes related to inadequate carbohydrate consumption.  
 
Parents should be advised that postprandial bolus insulin is problematic as it can become an 
established habit and also reinforces anxiety about the child under-eating. Fear of 
hypoglycemia can lead to under-bolusing for meals, resulting in inadequate bolus doses given 
over the day and subsequent hyperglycemia. Continuous eating (grazing) makes interpretation 
of glucose levels and insulin dose adjustments difficult. A regular meal pattern with one small 
snacking episode between meals (7 to15g CHO) will assist with preventing food refusal as the 
child will be hungrier at main meals. A dietitian should advise regarding age appropriate 
carbohydrate amounts as it is necessary to ensure the anticipated carbohydrate intake is 
reasonable based on age, growth and the child’s previous intake. Unreasonable expectations 
of a child’s intake may result in food refusal and subsequent hypoglycemia.  Food refusal 
should generally be dealt with effectively and similarly to toddlers without diabetes. 
Preschool children becoming increasingly independent can recognise parental stress and 
quickly learn to use their diabetes as a way of getting their favourite foods. It is important to 
emphasise parental patience and to encourage parents not to use food bribes.   
 
All diabetes team members should provide the family with clear and consistent messages 
regarding food and meal-time behaviours. Distractions such as the television and toys should 
be removed at mealtimes. Research has demonstrated that disruptive child behaviours can be 
reduced by establishing specific rules and consequences for mealtimes and teaching parents 
behavioural strategies for meals (104).    
 
There is consensus that continuation of support by a pediatric dietician throughout childhood 
and adolescence is essential for optimal care. 
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❖ In parental experience, it can be difficult at times to give pre-prandial bolus doses of 
insulin due to the fear of food refusal and resultant hypoglycemia. Strategies to handle 
this need to be discussed with the parents (as above) and the risk of all aspects of 
dysglycemia following postprandial bolus doses need to be explored.  
❖ Should a child have a high plasma glucose because of eating something unplanned, a 
calm explanation of the need to cover food with insulin is necessary.  
 
 
Lifestyle factors in preschool children 
The American Heart Association (AHA) has identified certain childhood conditions 
(including type 1 diabetes) associated with extremely high risk of cardiovascular disease, 
calling for treatments to minimise this risk (105). 
 
Lifestyle habits, such as nutritional preferences (92), physical activity (106) and time spent 
sedentary (107), that are established in childhood have a great propensity to follow into 
adulthood. Thus, lifestyle factors in early childhood have a dual impact on later 
cardiovascular risk, observable both as early markers of atherosclerosis during adolescence 
(108) and also as a set of behaviours that influences the child’s risk of cardiovascular disease 
as an adult and even into senescence. 
 
Children tend to follow the lifestyle habits of their parents and entire family regarding 
physical activity (109), TV watching (110) and food choices (97, 111, 112), and this has been 
found to influence children´s food habits throughout their lives (92). Lifestyle supporting 
interventions should thus be directed towards the parents and entire family and not the 
individual child with T1DM. 
 
There is no contradiction between population-based interventions to promote increased 
physical activity or healthier food choices in all children and interventions that are routinely 
part of the diabetes care delivered by the diabetes team. Preschool children with type 1 
diabetes could benefit from both efforts, but targeted interventions are necessary to meet the 
specific needs of children with type 1 diabetes. 
 
Physical activity 
 
Physical activity confers many health benefits for healthy children. A strong graded inverse 
cross-sectional association has been observed between physical activity and insulin resistance 
(113, 114) and body fat (115). Spending more time in moderate and vigorous physical activity 
is associated with decreased cardiometabolic risk factors in children (116). When designing 
physical activity interventions to reduce the risk of cardiovascular disease in children, 
including children with type 1 diabetes, it is important to focus on high-intensity physical 
activity to be most effective (116). Engaging in regular physical activity is also necessary in 
order to acquire and improve gross motor skills (117).  
 
Many countries recommend at least 60 minutes per day of moderate and vigorous physical 
activity for all children (118), and WHO recommends this at least from five years of age 
(119). Some countries have changed their recommendations for physical activity in preschool 
children from 60 minutes of moderate and vigorous physical activity to 180 minutes of any 
intensity of physical activity per day (120, 121). This change of recommendation has been 
questioned because the reduction in the risk of cardiovascular and metabolic problems might 
be too low with lower intensity of physical activity (115, 116). 
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It has been shown that outdoor playing and especially spacious outdoor playing environments 
are associated with increased physical activity in preschool children (122). Asking families 
about the amount of time spent playing outdoors can be a useful way to quantify the physical 
activity of a preschool child with type 1 diabetes. 
 
Physical activity should be promoted in all children with type 1 diabetes. Both having 
diabetes and being a girl has been reported to be associated with lower levels of physical 
activity in preschool children with type 1 diabetes, indicating that particularly young girls 
with type 1 diabetes are at high risk of being too physically inactive (123). 
 
Practical monitoring of glycemic control 
In this chapter, “plasma glucose” values refer to glucose values measured by capillary blood 
test (“finger prick”, “blood glucose monitoring”).  
Plasma glucose (SMBG) 
Glycemic control is often evaluated with plasma glucose monitoring (SMBG). All families 
with a child with diabetes should be taught how to measure and interpret plasma glucose 
values. A high precision glucometer (error less than 10%) should be used in preschool 
children, both when relying on SMBG for glycemic monitoring and when using the 
glucometer for calibration of CGM. Accuracy in everyday monitoring situations should be 
ensured by follow-up with the diabetes team. This shall include education on the importance 
of ensuring that the fingertips are clean and dry before monitoring plasma glucose, as sugar 
on the fingertips is a common reason for erroneously high glucose levels. The child should be 
introduced to glucose monitoring and interpretation according to age appropriate and 
individual capabilities, as the development of the mathematical understanding of numbers and 
time is gradual.  
Most children with type 1 diabetes can by the age of seven years be capable of taking plasma 
glucose tests and performing some basic interpretation of glucose levels under supervision. 
However, this should always be overseen by a parent or other caregiver, since independent 
self-care is not expected from any preschool child with type 1 diabetes.   
General advice on SMBG monitoring is available in the ISPAD Guidelines on Assessment 
and monitoring of glycemic control (29). In children younger than seven years of age, the 
recommended testing frequency of 4-6 times per day is rarely sufficient when striving for 
target glucose and HbA1c. Even with a higher testing frequency of 7 or 10 tests per day, the 
number of undetected hypo- and hyperglycemic events in insulin treated preschool children 
are high (124, 125).  
Observational studies from different countries show that a common frequency of SMBG in 
preschool children with type 1 diabetes is 7-10 tests per day (125, 126). Nighttime SMBG is 
recommend by many diabetes teams, and performed by most families with preschool children 
(127). Preschool children with diabetes can spend a long time in the hypoglycemic range 
without detection, despite night-time monitoring of SMBG (125). 
Many parents are sleep-deprived due to night-time testing of plasma glucose (127, 128). The 
normal activities of the child have to be interrupted in order to measure a plasma glucose 
value during daytime. Thus, SMBG has several limitations as method of monitoring glycemic 
control. 
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❖ Parent experience from Children with diabetes (CWD) conferences: “I have seen 
many young children in the age group of 5-6 who understand both the numbers and 
trend arrows on their CGM”. We also know from personal experience that children 
who are diagnosed young sometimes grasp ‘the numbers’ of diabetes very quickly.  
Continuous glucose monitoring (CGM) 
CGM can provide an effective mode of monitoring for low and high glucose levels, 
allowing for efficacious insulin adjustment. When available, CGM with alarms is generally 
the preferred method for monitoring of glucose levels in children younger than seven years of 
age with type 1 diabetes. CGM should be available and utilized as a tool for adjusting insulin 
doses. 
• Data on CGM use in preschool children are limited, but suggest low overall rates of 
use (126, 129), often due to financial constraints.   
• Parental satisfaction with CGM use is high, in large part because the technology can 
decrease the likelihood of severe hypolycemia (130). 
• When parents/caregivers share their thoughts and interpretations, real-time CGM 
information, including a color coded screen with arrows, and alarms can often be  
understood by preschool children from around age 5-6 years. Talking with the child in 
an age-appropriate way about actual CGM information gradually increases the child´s 
understanding and participation in their insulin treatment.  
• Even if children can have some understanding of this, interpretetaion and necessary 
steps of action are always the responsibility of the parent/caregiver. 
• Use of CGM devices in preschool children can be hampered by issues of adhesion and 
skin irritation (131, 132).   
• The ability of some CGM devices to remotely transmit glucose values to a phone can 
be of benefit for parents/caregivers who rely on others for part-time care of their child 
with diabetes, for example while at daycare or preschool. 
• CGM enables deepened analysis and understanding of glycemic patterns (such as 
postprandial glycemic excursions), and downloading data from the device is a 
pedagogic tool for the team when discussing solutions to various problems with the 
parents of a child with diabetes.  
• Downloading at home by parents should be encouraged, and can form a basis for self-
adjustment of insulin doses for experienced families. 
 
 
Use of insulin pumps with and without CGM in preschool children 
Preschool children are unique consumers of novel insulin delivery and device technologies, as 
they are dependent on caregivers for all aspects of device use. Recent technologies, such as 
pumps and CGM, can be particularly helpful to parents and caregivers of preschool children 
who are extremely dependent on fine-tuning of small insulin doses, both with regard to size 
and timing of insulin doses. 
 
An insulin pump system is available that can suspend insulin delivery when glucose levels, as 
measured by CGM, are predicted to become low, and thus reduce the risk and duration of 
hypoglycemia (133). On the other hand, insulin pumps and CGM are associated with 
increased cost and may increase the provider burden; insulin pumps may also carry additional 
risks associated with pump and infusion set malfunctions.  
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• Insulin doses in preschool children need to be modified frequently as children of this 
age are growing rapidly and have changing patterns of eating and sleeping.   
• The decrease in size of insulin pumps and CGM devices (including the infusion 
sets/sensors) over the past few years make these therapies more acceptable for 
preschool children. 
• The safety of insulin pump and CGM use in this population appears to be similar to 
that seen in other age groups (130, 134). 
• It is essential for the family to have access to blood ketone testing to detect problems 
with the supply of insulin from the pump. See the section on ketone monitoring below 
and the ISPAD guideline on sick days (135).  
• Regular downloading of data from the pump (and CGM if used), both at home and in 
clinic, allows patterns of dosing (136) and glucose levels to be recognizable. 
• Always give extra insulin with a pen or syringe in case of suspicion of problems with 
insulin delivery from the pump.  
• If the child is prone to ketosis, replacing part of the overnight basal (30-40%) with a 
small dose of long-acting insulin (detemir or glargine) may help, but might also reduce 
the flexibility in basal insulin administration by temporary basal rates. 
• Parents of preschool children who switch from multiple daily injections to insulin 
pumps report more flexibility and freedom, as well as less stress and anxiety related to 
their child’s care (137). 
• Data suggest a decrease in HbA1c (129, 134) and reductions in rates of severe 
hypoglycaemia (95, 134) after implementation of insulin pumps in preschool children. 
• Insulin pump features that enable automatic bolus calculations based on insulin 
sensitivity factors and insulin to carbohydrate ratios can aid caregivers in insulin 
administration.  
• Insulin pump therapy may be effective in helping to manage toddler-eating behaviors 
by facilitating split bolus dosing. 
• The pump calculates “insulin on board”, i.e. how many units from a previous dose of 
insulin that still exerts a glucose-lowering effect. A phone app that can calculate 
“insulin on board” can be used for calculation of bolus doses of insulin when on 
injection therapy. 
• Although CGM provides an overwhelming amount of data, it is important to look for 
daily patterns (for example the “modal day” when downloading data), and adjust 
insulin-to-carbohydrate ratios and correction factors only after a repeated pattern has 
been found.  
• The frequency of insulin pump and CGM use varies between centres. Barriers to the 
use of these treatment options in preschool children need to be explored. 
 
Skin Care 
There are very few data on special considerations regarding skin care in preschool children 
with type 1 diabetes but CGM-related skin problems seem to be most common in very young 
users (132). CGM-related skin problems are not associated with atopy (138). In general, 
recommendations for site use (including site selection, site preparation, site rotation) are 
similar as for older children. Many preschool children receive insulin injections and insert 
infusion sets and CGM sensors in their buttocks, an area often covered by a diaper. The 
abdomen, upper arm, and upper thigh regions are also commonly used. For children under the 
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age of 6 using insulin pumps, data suggest that rates of scarring and lipohypertrophy are high 
(50% and 45% respectively) but not different than in older children (139).   
• Injection, infusion, and CGM sites should be properly prepared and regularly rotated 
in order to reduce the likelihood of lipohypertrophy, superficial scarring, infection, 
rashes, skin reactions and dry skin.  
• Injection, infusion and CGM sites should be inspected by diabetes team members at 
every visit to the clinic to detect any skin problem or lipo-hyper/hypotrophy early, in 
order to treat promptly. 
• The use of pumps and CGM are often limited by skin reactions to the adhesive. 
Prepare the site a few days prior to insertion by the use of a skin moistener that 
preserves water. Topical cortisone (group I or II) can be used to treat skin reactions 
and break the vicious circle of itching after removal. 
 
Ketone monitoring 
 
Measuring ketone bodies in blood (betahydroxybutyrate, BOHB) should be recommended as 
the primary method of detecting and monitoring ketosis in preschool children with type 1 
diabetes; see the ISPAD Guidelines on Sick days (135). Measurement of acetoacetate in urine 
can be used as an alternative, but gives less precise information. As preschool children do not 
urinate on command, especially when sick, results from blood ketone testing will be more 
easily available both for the child and parent. Blood ketone testing also gives the healthcare 
professional much better information to provide advice over the phone or in the emergency 
room. 
 
Ketones should be monitored when there is a suspicion of lack of insulin raised either by high 
blood glucose (two values above 14 mmol/l within two hours that does not decline on a 
correction insulin dose) or when the child shows symptoms suggestive of ketosis (vomiting, 
nausea, stomach pain, fever, “unclear illness”).  
 
Elevated glucose levels and ketone levels suggest lack of insulin and should promptly be 
treated with injection of insulin 0.1 U/kg (or 10% of TDD) every second hour until BOHB is 
below 0.5 mmol/l. If levels are above 3.0 mmol/L, the family should seek guidance by phone 
or in person immediately, possibly in an emergency room, due to the high risk of 
ketoacidosis. Slightly elevated BOHB (usually <1.0 mmol/mol) in combination with normal 
or low glucose levels indicates combined lack of carbohydrate and insulin, commonly 
associated with gastroenteritis in preschool children. This can most often be treated at home 
with ingestion of sugary fluids and administration of extra insulin subcutaneously. See the 
ISPAD Guidelines on Sick days for further advice (135). 
 
Ketoacidosis is a life-threatening acute complication of diabetes that demands care at a skilled 
hospital unit. Six percent of children younger than six years in the US and 4% of children in 
Germany/Austria (from data from the Type 1 Diabetes Exchange clinic registry and the 
Prospective Diabetes Follow-up Registry: DPV) have suffered from ketoacidosis during the 
past year (45). Education of families on prevention of ketoacidosis is an essential part of 
diabetes care (140). See the ISPAD Guidelines on Diabetic Ketoacidosis for further advice 
(140). 
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Hypoglycemia   
Hypoglycemia, including fear of hypoglycemia, is a limitation to striving for normoglycemia. 
The risk of hypoglycemia presents a major physiological and psychological barrier to 
achieving optimal glycemic control, and may result in significant emotional morbidity for 
patients and caregivers (29, 141, 142). Young age is traditionally regarded as a marker of high 
risk of severe hypoglycemia during insulin treatment (29).The frequency of severe 
hypoglycemia has decreased over time in all children (29, 35, 143, 144). In Germany and 
Austria, fewer than 2 % of children younger than six years with type 1 diabetes have 
experienced a severe hypoglycemic event with seizures/unconsciousness during the previous 
year; in US this figure is less than 3% (126).  
 
The erratic daily life of a preschool child (food intake, activity, sleep, sick days) has been 
regarded as the explanation for the historically high risk of severe hypoglycemia in preschool 
children with type 1 diabetes. Preschool children are not yet able to identify and articulate 
their symptoms and it can be very difficult for caregivers to detect these symptoms. Prolonged 
nocturnal hypoglycemia is not uncommon in children younger than seven years with type 1 
diabetes as detected in CGM studies (125, 145-147),which is associated with a higher risk of 
severe hypoglycemia (146).  
 
The fear of an hypoglycemic event, rather than the frequency of hypoglycemic events, is 
associated with higher HbA1c and poorer HRQoL (141). The role of fear of hypoglycemia 
cannot be underestimated for parents of children with type 1 diabetes (142). Asking about 
frequency and severity of hypoglycemia is typical in a clinic visit, but it may also be helpful 
to ask about thoughts and feelings during and after the hypoglycemic event. Fear of nocturnal 
hypoglycemia is a particular challenge (142).  Fear is not correlated with the numbers of 
hypoglycemic episodes, but is related to their severity, especially in mothers of children who 
have experienced a hypoglycemic seizure.   
The use of insulin pumps and CGM has been reported to decrease the risk of hypoglycemia 
(148, 149). Insulin pumps with low glucose suspend features appear to further reduce the time 
spent in hypoglycemia (150, 151). 
 
The comparison of data between the United States T1D Exchange and German/Austrian DPV 
registries showed that an HbA1c of <7.5% (<58mmol/mol) can frequently be achieved in 
children younger than six years with type 1 diabetes  without an increased risk of severe 
hypoglycemia (126). In many countries, children younger than seven years most frequently 
have the lowest HbA1c. In Sweden, 74% of insulin treated children younger than seven years 
have HbA1c < 7.4% (< 57mmol/mol), and the overall frequency of severe hypoglycemia 
(seizures/unconsciousness) in the pediatric age (0-18 y.) is 2.5% (152).  
 
For definitions and further information see the ISPAD Guidelines on Hypoglycemia (29). 
 
Treatment of mild hypoglycemia in infants and preschool children 
 
Oral glucose as tablets, gel or a drink (0.3 g glucose/kg bodyweight) is the preferred method 
of hypoglycemia treatment (29, 153). This dose will raise plasma glucose approximately 2.5-
3.6 mmol/l (45-64 mg/dl) (29). It is important not to give too much carbohydrate when 
treating hypoglycemia, in order to avoid subsequent hyperglycemia. Giving something that 
contains fat (i.e. milk, chocolate) will slow down the gastric emptying, and cause a slower rise 
in plasma glucose (154). Sucrose sweetened confectionary should not be routinely used to 
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treat hypoglycemia, as it can lead to increased risk of dental caries and food refusal if the 
child learns that sweets are substituted for unconsumed food. It is important that 
hypoglycemia is not over-treated, as 5-7 g carbohydrate is usually adequate in raising the 
plasma glucose to normal levels for small children using intensive therapy.  
 
To treat hypoglycemia in breast- or formula-fed infants, carbohydrate gel, diluted juice or a 
glucose polymer from a spoon or bottle can be offered. Honey should not be given to infants 
younger than 1 year due to risk of botulism. 
Screening for associated diseases 
Early onset of type 1 diabetes is associated with a higher frequency of celiac disease 
compared with older children, which affects the treatment situation of the child (155-157), 
and may influence the risk of complications and quality of life. Repeated screening for celiac 
disease, thyroid disease and other autoimmune disorders is essential (158). 
Living with diabetes in the family 
For people living with type 1 diabetes and their families, the management of the condition is 
complex and individual. Daily challenges imposed by type 1 diabetes include cognitive and 
emotional burdens that can take the form of increased vigilance to dietary intake, symptom 
monitoring and frustrations with glucose excursions. For caregivers of preschool children 
with type 1 diabetes, additional complexities are encountered, including the necessity to adapt 
to developmental changes to ensure adequate psychological adjustments for the child and 
themselves, and to facilitate care in the context of other care providers such as preschool staff 
(159). Clinicians need to be aware of the overwhelming sense of responsibility and worry 
which parents of preschool children with type 1 diabetes can feel. Parents who have access to 
a supportive network (relatives and/or friends) have lower risk of diabetes related stress and 
burn-out (128). It is important to educate secondary caregivers about type 1 diabetes and 
insulin treatment. Attention should be given to the needs of the siblings of a child with type 1 
diabetes. 
As children grow, they understand more about health and illness. When appropriate, it needs 
to be explained that diabetes is not caused by eating too much sugar, and that you cannot 
catch diabetes from another person. This needs actively to be taught to friends and relatives as 
well to avoid common misconceptions about diabetes.  
Parents are an integral part of the diabetes team and have the most important supportive role 
to play over the years as their children eventually learn to self-manage their diabetes. 
Providing this support can be difficult when parents have their own stressors to deal with, and 
struggle with the constant vigilance needed to ensure the safety of their child. Dashiff et al  
(160) report that parents of older children with type 1 diabetes experience an ongoing 
struggle, worry and frustration about their parenting role. During young childhood, parents 
take responsibility for all diabetes-related tasks such as insulin administration, dosing 
calculations, blood glucose testing, and so on.  It is important that they do this in a way that is 
neither threatening nor frightening for their child. Involving the child in aspects of diabetes 
management as soon as possible (for example finger pricks and carbohydrate counting) is 
recommended, so the child can begin to develop a sense of ownership/management of their 
own health. A supportive and emotionally warm parenting style is important for promoting 
improved quality of life for children with type 1 diabetes (161). 
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Establishing good habits in the early years will form the basis for optimal diabetes self-
management during adolescence and into adulthood (2, 92, 106, 107). In order to create an 
environment in which parents feel confident and comfortable, it is crucial that they are 
appropriately supported by all members of their multi-disciplinary team and that they have 
adequate access to appropriate support when they need it. The way that parents model 
diabetes-related tasks will have a direct impact on the way their children learn.  Supporting 
parents towards a positive adjustment to living with diabetes will help them to effectively 
model those tasks and assignments involved in daily life with diabetes. It is important to 
engage both fathers and mothers in diabetes care from the onset, and to keep them both 
involved in everyday diabetes care throughout the childhood years.   
❖ Parents express that it is important to explain to their child in very simple and clear 
terms what type 1 diabetes involves. There are certain aspects of diabetes management 
that are not negotiable (glucose checking, insulin injections/pump site changes, CGM 
use, etc), and the child needs to begin to understand that as early as possible. It is 
important to involve the child in diabetes management as soon as possible so they can 
begin to develop a sense of ownership/management of their own disease. Reinforcing 
such an attitude early on will help to shape the child’s attitude and approach to 
diabetes in the future. 
 
❖ Parents report that diabetes will often initially disrupt the normal parent-child 
relationship, as diabetes frequently comes first in the mind of the parent in response to 
a child’s requests. It is important for parents to ask themselves, “If my child didn’t 
have type 1 diabetes, would I say no to this request?”, and thus strive to re-establish 
the normal parent-child relationship. 
   
Screening children for psychosocial distress 
Regular screening of children for psychosocial distress is important to ensure that difficulties 
are identified early, and appropriate support and treatment plans established as soon as 
possible. Most children are not able to complete questionnaires or report on their own level of 
emotional distress in a reliable manner until they are approximately 7-8 years of age. 
Therefore, either talking with them directly about how they feel, or asking their parents to 
report on their children’s psychosocial well-being is recommended. For children that are 
older, there are several paediatric measures of depressive symptoms that are validated and 
reliable for use with children as young as 7 years of age, varying in length and depth of detail.  
These include the Children’s Depression Inventory (CDI) (162) and the Center for 
Epidemiologic Studies – Depression (CES-D) scale (163). Both measures are self-reported 
questionnaires containing items on types of symptoms (e.g. sadness, low self-esteem) and 
functional areas (e.g. not having friends, schoolwork is not as good as it was before, arguing 
with others). Pediatric quality of life can be addressed by specific questionnaires such as the 
Pediatric Quality of Life Inventory (PedsQL) generic and Type 1 Diabetes modules (164). 
These measures offer a child self-report for youth ages 5-7 and also for youth ages 8-18 years. 
There are also PedsQL parent proxy reports for children ages 2-18 years (164). Diabetes-
specific emotional distress can be assessed in children ages 8-11 (PAID-C) and teens (PAID-
T) and parent’s diabetes-specific emotional distress can also be assessed (P-PAID-C and P-
PAID-T) in measures developed by Weissberg-Benchell and colleagues. Similarly, diabetes-
specific emotional distress from age 8 can be assessed by the PAID-Parent (PAID-PR) scale 
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and from age 8 years in youth with the PAID-Peds scale, both developed by Markowitz et al 
(165, 166).  
 
Parental anxiety can have a direct and negative effect on diabetes management and health 
outcomes. There can often be a co-morbidity of depression; however they are two separate 
conditions and should be treated separately. They may act in opposite directions with regard 
to diabetes management and control, so we recommend assessing anxiety separately from 
depression. The CESD is often used as a measure of depressive symptoms in adults, and the 
Beck Depression as well as the Beck Anxiety scales are also often used. Worries about 
diabetes impact on glycaemic control in children and should be acknowledged and addressed. 
 
Preschool care 
Many preschools provide excellent care for children with type 1 diabetes. Parents and 
healthcare professionals should work together to overcome any difficulties and ensure the 
safety and well-being of the child with type 1 diabetes when cared for outside the home 
setting. It is crucial that every child is supported effectively to achieve their full potential. 
Legislation protects children with type 1 diabetes in many countries. One example is the 
Equality Act 2010 (England, Scotland and Wales) which dictates that schools must make 
reasonable adjustments to ensure that children with disabilities are not put at a substantial 
disadvantage compared with their peers. For diabetes this means schools ensuring they have 
enough staff trained so that the child with diabetes can take part in all aspects of preschool 
and school life. Contingency plans must be in place to train replacement staff quickly. The 
Kids and Diabetes in Schools (KiDS) program of the International Diabetes Federation (IDF) 
offers education and guidance for families and school staff on ways to help children with type 
1 diabetes manage in school. KiDS information is available in eight languages (as of 
September 2015) and can be accessed online at http://www.idf.org/education/kids.  
In addition to ensuring the rights of the child with diabetes, it is important to create trust and 
cooperation between the preschool, the family and the diabetes team. An individually written 
diabetes management plan is helpful in this cooperation to help the child with type 1 diabetes 
(167), and should include information about and practical training for the use of diabetes-
related technologies (168). Both the parents and the diabetes team need to share the 
responsibility for educating the preschool institution, especially when the child is newly 
diagnosed with diabetes or when additional diagnosis such as celiac disease occurs. Preschool 
staff often find carbohydrate counting helpful as it gives them a tool to assess the dose of 
insulin to be given in relation to the food intake and current glucose level. In countries where 
there are no regulations to support the child with diabetes, the diabetes team together with the 
parent organisations should advocate for improved regulations. 
❖ Parents express that while regulations certainly help to ensure documentation and 
agreements on daily care, maintaining a close relationship with the school (staff, 
teachers, etc) is equally if not more important to ensure effective daily management of 
their child's diabetes. Parents can be in very close contact with the school, including 
offering training sessions, educational materials for other parents etc, which will lead 
to better and more effective diabetes management. This helps them to feel more 
comfortable/less stressed when sending their child to preschool.  
 
Alternative and complementary therapies 
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At times families try alternative indigenous remedies and even discontinue insulin. This can 
be avoided if parents are counselled regarding the absolute necessity of insulin for the child’s 
survival. Alternative therapies may be tolerated if important for the family as long as they do 
not interfere with the regular diabetes care, including insulin doses, glucose monitoring and 
healthy food choices, or impact the child’s growth or development or deplete economic 
resources needed for insulin treatment.  
Care for the preschool child with type 1 diabetes in limited resources settings 
Whenever possible, the guidelines described above in the preceding sections should be 
followed.  
It is important to remember that building a good rapport with the family and providing 
comprehensive diabetes education are inexpensive, and remain the most effective strategies to 
improve diabetes management by the family (37). Knowledge about the effects of insulin, 
food and physical activity on glucose levels are essential to protect the child from acute and 
chronic complications of diabetes under all circumstances. The first few visits of the family 
are the most crucial in this regard. Initial approach to diagnosis and treatment is based upon 
staffing and facilities at specialized centers for the care of young children with diabetes, with 
many centers recommending hospitalization. Parents should be counselled and educated in 
detail.   
The challenges in managing type 1 diabetes in the preschool child are several-fold higher in 
resource limited settings. Awareness, health infrastructure and number of medical 
professionals trained in the management of childhood diabetes are inadequate for a significant 
proportion of the population in many countries in South East Asia and sub-Saharan Africa. 
The diagnosis is often delayed, and may even be missed in some cases, resulting in death 
before diagnosis. Common misdiagnoses are gastroenteritis, pneumonia, asthma, urinary tract 
infection, genital tract infection (candidiasis), enuresis and malaria. Parents may take longer 
to come to terms with the diagnosis and the need for life-long insulin therapy. The financial 
implications of the condition add to the psychological distress brought about by the diagnosis. 
Risk of acute and chronic complications, as well as mortality is higher in these children due to 
sub-optimal management (169). In the US, young people of African descent have increased 
risk of short-term complications (ketoacidosis and severe hypoglycemia) when adjusted for 
socioeconomic status (170), and higher HbA1c even when adjusted for mean glucose levels 
(171). HbA1c was higher even when fasting glucose is < 7 mmol/l in black individuals both 
with and without diabetes compared to white, but the prognostic value of HbA1c for 
predicting cardiovascular disease, nephro- and retinopathy were similar (172). 
The financial issues need to be addressed upfront by the treating team. The challenge of 
finding ways to support the families lies chiefly with the care providers. The team should be 
familiar with the governmental and non-governmental agencies in the area that may provide 
financial assistance for procuring insulin and glucose strips, and ensure that parents have 
access to these before the child is discharged home.   
Most preschool children in resource-limited settings remain on Regular and NPH insulin 
administered by insulin syringes. With only Regular and NPH available (as in the DCCT 
study), a multiple injection therapy with regular insulin for meals and NPH insulin at bedtime 
can be effective in teaching the family the relationship between insulin dose and carbohydrate 
content of the meal. Carbohydrate counting can be used in this situation. The challenge to 
overcome will be the lunchtime injection at school. It is very important to motivate and 
explain this to the school staff as the alternative of giving a twice daily mixture of Regular 
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and NPH does not result in a physiological insulin profile. In a situation where food 
availability is unpredictable, a child on twice daily injections will experience hypoglycemia, 
while the child on multiple injections can adjust mealtime doses accordingly. 
Few patients are able to afford analog insulin and pen devices. The use of insulin pumps is 
affordable by a low percentage of the population. Administration of small doses is therefore a 
practical challenge. In young infants, parents may be taught to dilute insulin with normal 
saline (available in 10 ml vials). The use of syringes with 30 U in 0.3ml allows an accurate 
administration of half units, appropriate for most preschool children. Similarly, use of CGM 
remains unavailable for most children with type 1 diabetes in the resource-limited scenario, 
and frequent self-monitoring of plasma glucose is the only method for monitoring glycemia. 
However, even this may not be feasible for some families due to the high cost of glucose 
strips. If possible, the child can be recommended a meal plan with a relatively consistent 
carbohydrate intake at meal and snack times during the day to match the insulin regimen. The 
family can be taught to have a high index of suspicion for hypoglycemia and treating it on 
suspicion, relying mostly on urinary glucose monitoring, and to use SMBG at least on sick 
days if available (173). With limited number of strips, the family can, for example, measure 
before and 2 hours after lunch one week, and before and after dinner the next to get a more 
stringent picture of the day compared to random checks. 
Another issue that may compound the challenge in resource-limited settings is that some 
parents may have low levels of literacy and health literacy, meaning thereby that they cannot 
read the numbers on the insulin syringe and on the glucometer. For example, in India, literacy 
rate is 74.04% according to the 15th official census in 2011, 
(http://www.census2011.co.in/literacy.php). In such cases, it is helpful to identify a suitably 
literate relative, friend or neighbour who can undergo diabetes education along with the 
parents and assist them in the domiciliary management. The parents should also be 
encouraged to learn the basics of reading and writing. In case of low literacy, a simpler insulin 
regime such as twice daily dosing with pre-mixed insulin can be given. Hearing the number of 
clicks from an insulin pen can obviate the need to read the number of units. Teaching the 
parents to recognise ‘Hi’ and ‘Lo’ on glucometer, to treat hypoglycemia based on symptoms 
alone, and to recognize hyperglycemia and ketonuria by urinary strips is also useful to prevent 
life-threatening episodes.  
Vomiting in a child with diabetes should always be regarded as imminent ketoacidosis, and 
appropriate treatment should be sought immediately in the absence of knowledge and 
diagnostic measurements. If the child is not feeling well with other symptoms, the first line of 
treatment should be something containing sugar to treat impending hypoglycemia. This 
should be well known by all the older children and adults that are close to the child with 
diabetes, and they should know where to readily find a source of sugar. 
To conclude, the goals of management of type 1 diabetes in resource-limited settings must be 
situated in the context of the resource limited environment and based on the family’s 
educational and financial status. Avoidance of acute life-threatening complications and 
continuation of regular treatment and follow-up are the immediate goals.  
 
 
 
Future needs of preschool children with type 1 diabetes  
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“Diabetes during early childhood creates a psychosocial challenge to the families of these 
children. Successful management of infants and toddlers with diabetes depends on a well 
functioning and educated family, the availability of a diabetes health care team experienced 
in the treatment of these youngsters, and the involvement of the extended family, child care 
personnel and others who play a role in their daily care” (Daneman 1999) (174). 
The addition of new tools should enable families living with type 1 diabetes to provide 
increasingly effective therapy and support for preschool children with diabetes. The cognitive, 
motor and social immaturity, as well as the small body size of preschool children must be 
considered when designing new equipment, including sensors, insulin pumps and (semi) 
closed-loop solutions for insulin delivery.  
It is important to include children younger than seven years in both epidemiological and 
clinical studies regarding treatment strategies and tools (both technical equipment and 
pharmacological) and outcomes; moreover, when the youngest children with type 1 diabetes 
are included in these studies, data regarding children with early-onset diabetes must be 
presented separately to enable subgroup analysis. Children younger than seven years with 
type 1 diabetes constitute only approximately 10% of the population of all children and 
adolescents with type 1 diabetes (126, 152), but in many countries the incidence in this 
subgroup is increasing most quickly. Collaboration between centres is thus necessary in order 
to conduct studies that are sufficiently powered. 
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